What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Pharma Industry News Clearmind Medicine files U.S. patent for non-hallucinogenic MEAI therapy targeting cocaine addiction Find out how Clearmind Medicine’s new U.S. patent filing for its non-hallucinogenic MEAI therapy could transform cocaine addiction treatment and investor sentiment. bySoujanya RaviOctober 31, 2025